Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC

BACKGROUND & AIMS: Antiviral treatment is known to improve survival in patients with chronic hepatitis B (CHB)-related hepatocellular carcinoma (HCC). Yet, the treatment uptake in CHB patients remains low. We aimed to report the secular trend in antiviral treatment uptake from 2007–2017, and to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JHEP Rep
Main Authors: Hui, Vicki Wing-Ki, Chan, Stephen Lam, Wong, Vincent Wai-Sun, Liang, Lilian Yan, Yip, Terry Cheuk-Fung, Lai, Jimmy Che-To, Yuen, Becky Wing-Yan, Luk, Hester Wing-Sum, Tse, Yee-Kit, Lee, Hye-Won, Chan, Henry Lik-Yuen, Wong, Grace Lai-Hung
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7530304/
https://ncbi.nlm.nih.gov/pubmed/33024950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2020.100152
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares